Ferrous fumarate 75 MG Chewable Tablet — RxCUI 1095223
RxNorm drug concept · Semantic clinical drug
RxCUI 1095223
Semantic clinical drug · SCD
● Current RxNorm concept 8 FDA products
11 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1095223
Official nameFerrous fumarate 75 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped8
Package NDCs mapped11
Reported Medicaid activity (SDUD)3,744 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Ferrous fumarate 75 MG Chewable Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ferrous fumarate 75 MG Chewable Tablet
RxCUI 1095223 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ferrous fumarate
24941IN
-
Ferrous fumarate
-
Dose forms 8
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ferrous fumarate Chewable Tablet
372169SCDF -
Ferrous fumarate Chewable Product
1295725SCDG -
Ferrous fumarate Oral Product
1159640SCDG -
Ferrous fumarate Pill
1159641SCDG -
Chewable Tablet
91058DF -
Chewable Product
1294716DFG -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Ferrous fumarate Chewable Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ferrous fumarate 75 MG
358518SCDC
-
Ferrous fumarate 75 MG
-
Packs 9
Fixed collections of drugs packaged and sold together, like dose packs.
-
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Nexesta Fe 28 Day]
1869047BPCK -
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Wymzya Fe 28 Day]
1486452BPCK -
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Xelria Fe 28 Day]
2703268BPCK -
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Zenchent Fe 28 Day]
1483558BPCK -
{24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Galbriela 28 Day]
2704559BPCK -
{24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Kaitlib Fe 28 Day]
1727521BPCK -
{24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Layolis Fe 28]
1650201BPCK -
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack
1095224GPCK - +1 more in this family
-
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Nexesta Fe 28 Day]
Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack
GPCK · 1095224 -
{24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack
GPCK · 1607990 -
Ferrous fumarate 75 MG
SCDC · 358518 -
Ferrous fumarate Chewable Tablet
SCDF · 372169 -
Ferrous fumarate Chewable Product
SCDG · 1295725 -
Ferrous fumarate Oral Product
SCDG · 1159640 -
Ferrous fumarate Pill
SCDG · 1159641
Brand-Name Concepts
-
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Nexesta Fe 28 Day]
BPCK · 1869047 -
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Wymzya Fe 28 Day]
BPCK · 1486452 -
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Xelria Fe 28 Day]
BPCK · 2703268 -
{21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Zenchent Fe 28 Day]
BPCK · 1483558 -
{24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Galbriela 28 Day]
BPCK · 2704559 -
{24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Kaitlib Fe 28 Day]
BPCK · 1727521 -
{24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Layolis Fe 28]
BPCK · 1650201
📦 FDA Products & Package NDCs
8 products · 11 package NDCs
11 package NDCs map to RxCUI 1095223 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-7297-53 | 3 POUCH in 1 CARTON (0378-7297-53) / 1 BLISTER PACK in 1 PO... | NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | Mylan Pharmaceuticals Inc. | 2016-10-28 |
| 65862-0926-58 | 5 POUCH in 1 CARTON (65862-926-58) / 1 BLISTER PACK in 1 PO... | Nexesta Fe | Aurobindo Pharma Limited | 2017-02-02 |
| 65862-0926-87 | 1 POUCH in 1 CARTON (65862-926-87) / 1 BLISTER PACK in 1 PO... | Nexesta Fe | Aurobindo Pharma Limited | 2017-02-02 |
| 65862-0926-88 | 3 POUCH in 1 CARTON (65862-926-88) / 1 BLISTER PACK in 1 PO... | Nexesta Fe | Aurobindo Pharma Limited | 2017-02-02 |
| 65862-0926-97 | 72 POUCH in 1 CARTON (65862-926-97) / 1 BLISTER PACK in 1 P... | Nexesta Fe | Aurobindo Pharma Limited | 2017-02-02 |
| 68180-0873-73 | 3 POUCH in 1 CARTON (68180-873-73) / 1 BLISTER PACK in 1 PO... | WYMZYA Fe | Lupin Pharmaceuticals, Inc. | 2020-11-30 |
| 68180-0903-73 | 3 BLISTER PACK in 1 CARTON (68180-903-73) / 1 KIT in 1 BLIS... | Kaitlib Fe | Lupin Pharmaceuticals, Inc. | 2021-02-07 |
| 69238-1581-03 | 3 BLISTER PACK in 1 CARTON (69238-1581-3) / 1 KIT in 1 BLIS... | Zenchent FE | Amneal Pharmaceuticals NY LLC | 2018-06-29 |
| 70700-0306-85 | 3 POUCH in 1 CARTON (70700-306-85) / 1 BLISTER PACK in 1 PO... | GALBRIELA | Xiromed, LLC | 2025-01-29 |
| 70700-0308-85 | 3 POUCH in 1 CARTON (70700-308-85) / 1 BLISTER PACK in 1 PO... | Xelria Fe | Xiromed LLC | 2025-01-29 |
| 79929-0005-07 | 3 BLISTER PACK in 1 CARTON (79929-005-07) / 1 KIT in 1 BLIS... | Norethindrone and ethinyl estradiol and ferrous fumarate | Naari Pte Limited | 2022-12-31 |
Observed labelers:
Aurobindo Pharma Limited (4) ·
Lupin Pharmaceuticals, Inc. (2) ·
Amneal Pharmaceuticals NY LLC (1) ·
Mylan Pharmaceuticals Inc. (1) ·
Naari Pte Limited (1) ·
Xiromed LLC (1)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.